-Jawed Alam Researcher Activity Profile

Research Author Detailed Information 

Jawed Alam Publication Rate By Year

Jawed Alam has published 1 paper(s) in 2003, 2 paper(s) in 2006, 9 paper(s) in 2007, for a total of 12 research publications in total.

Jawed J Alam Author Information

LAST NAME: alam

FIRST NAME: Jawed

INITIALS: j

AFFILIATION:

Papers

Jawed Alam's Publication Record

1. Cleavage of the angiotensin II type 1 receptor and nuclear accumulation of the cytoplasmic carboxy-terminal fragment. Year Published: 2007
Ochsner Clinic Foundation, Ochsner Health System, 1516 Jefferson Hwy., New Orleans, LA 70121, USA. jcook@ochsner.org
2. AKT regulation of estrogen receptor beta transcriptional activity in breast cancer. Year Published: 2006
Center for Bioenvironmental Research, Tulane University, New Orleans, LA, USA.
3. Physiology and pathophysiology of heme: implications for kidney disease. Year Published: 2007
Mayo Clinic, 200 First Street, SW, Guggenheim 542, Rochester, MN 55905, USA.
4. Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Year Published: 2007
Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
5. Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Year Published: 2007
Division of Nephrology and Hypertension, Department of Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
6. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Year Published: 2007
Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA.
7. Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse beta-cells. Year Published: 2007
Department of Medicine, University of Colorado at Denver and Health Sciences Center, P.O. Box 6511, Mail Stop 8106, Aurora, CO 80045, USA. subbiah.pugazhenthi@uchsc.edu
8. Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. Year Published: 2007
9. Foreign body in submandibular region. Year Published: 2007
Department of Oto-rhino-larygology, Head and Neck Surgery, Dow Medical College and Civil Hospital. Karachi - Pakistan.
10. Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. Year Published: 2007
11. Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. Year Published: 2006
Department of Gastroenterology and Hepatology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. h.w.reesink@amc.uva.nl
12. The biosynthesis of GDP-L-colitose: C-3 deoxygenation is catalyzed by a unique coenzyme B6-dependent enzyme. Year Published: 2003
Division of Medicinal Chemistry, College of Pharmacy, and Department of Chemistry and Biochemistry, University of Texas, Austin, Texas 78712, USA.